As mentioned above, the combined therapy increased the expression of synapse-associated proteins (SYP and PSD95), and the results suggest that the protective effects of the combined therapy on mTOR may be related to its ability to increase synaptic plasticity in the hemorrhagic stroke. Here, MTOR is linked to hemorrhagic stroke.